|
Re: Third Eye, AHA, US Listing
|
7
|
Resverlogix Corp.
|
Sep 08, 2019 08:43AM
|
|
Resverlogix October 2018 events
|
7
|
Resverlogix Corp.
|
Oct 08, 2018 05:35PM
|
|
New publications
|
7
|
Resverlogix Corp.
|
Oct 08, 2015 02:46PM
|
|
Re: New Zacks SCR report "Apabetalone: A Potential Alzheimer's Play?"
|
7
|
Resverlogix Corp.
|
Aug 24, 2018 03:33PM
|
|
Re: New MD&A posted
|
7
|
Resverlogix Corp.
|
Dec 18, 2019 07:01AM
|
|
2019 Annual and Special Meeting of Shareholders and Webcast of Corporate Update
|
7
|
Resverlogix Corp.
|
Oct 29, 2019 12:06PM
|
|
ACC 2018 Late Breakers Announce
|
7
|
Resverlogix Corp.
|
Jan 23, 2018 03:30PM
|
|
Re: Looking at the language from the press release
|
7
|
Resverlogix Corp.
|
Oct 05, 2019 01:40PM
|
|
Re: Update
|
7
|
Resverlogix Corp.
|
Jun 12, 2019 10:00AM
|
|
Re: AGM
|
7
|
Resverlogix Corp.
|
Sep 11, 2018 11:28AM
|
|
Revamped RVX Homepage, New Content
|
7
|
Resverlogix Corp.
|
Jul 28, 2015 05:21PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
7
|
Resverlogix Corp.
|
Mar 27, 2020 10:43AM
|
|
Re: Please keep post respectful
|
7
|
Resverlogix Corp.
|
Jan 23, 2021 11:05AM
|
|
Re: What if RRR MACE is significant at 90% confidence?
|
7
|
Resverlogix Corp.
|
Apr 24, 2018 11:01AM
|
|
Re: Gordon Research Conference Presentation Thursday June 14th
|
7
|
Resverlogix Corp.
|
Jun 12, 2018 12:40PM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
7
|
Resverlogix Corp.
|
Apr 12, 2021 10:49AM
|
|
Re: AGM
|
7
|
Resverlogix Corp.
|
Dec 08, 2016 10:28AM
|
|
Zenith and RVX presenting at Biotech Showcase Jan 11-13 and Zenith AGM Jan 7
|
7
|
Resverlogix Corp.
|
Jan 04, 2016 07:25AM
|
|
Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
7
|
Resverlogix Corp.
|
Apr 12, 2021 10:54AM
|
|
Re: Bear
|
7
|
Resverlogix Corp.
|
Jun 06, 2020 01:12PM
|
